Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniele Forcella

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Robotic Surgery|March 26, 2023
Multimodal evaluation of locoregional anaesthesia efficacy on postoperative pain after robotic pulmonary lobectomy for NSCLC: a pilot studyRiccardo Tajè, Filippo Tommaso Gallina, Daniele Forcella, et al.
Frontiers in Oncology|December 16, 2022
Perioperative outcomes of robotic lobectomy for early-stage non-small cell lung cancer in elderly patientsFilippo Tommaso Gallina, Riccardo Tajè, Daniele Forcella, et al.
Frontiers in Oncology|November 29, 2023
Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLCFilippo Tommaso Gallina, Daniele Marinelli, Riccardo Tajè, et al.
Journal of Clinical Medicine|April 23, 2022
Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung CancerFilippo Tommaso Gallina, Riccardo Tajè, Daniele Forcella, et al.
Lung Cancer (Amsterdam, Netherlands)|July 30, 2024
Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLCFilippo Tommaso Gallina, Vittoria Balzano, Nicla Porciello, et al.
Clinical Lung Cancer|April 16, 2024
Neutrophil-to-Lymphocyte Ratio and Risk of Nodal Metastasis in Early-Stage Lung Adenocarcinoma: A Brief Report From a Multicentric AnalysisFilippo Tommaso Gallina, Marco Chiappetta, Riccardo Tajè, et al.
Journal of Clinical Pathology|August 17, 2021
Not enough can be enough: feasibility of the Idylla <i>EGFR</i> mutation test when reuse of stained tissue slides is the only option availableCristiana Ercolani, Anna Di Benedetto, Claudia Bonomo, et al.
Cancers|April 23, 2022
Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative ReviewFilippo Tommaso Gallina, Luca Bertolaccini, Daniele Forcella, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2023
ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinomaFilippo Tommaso Gallina, Riccardo Tajè, Fabiana Letizia Cecere, et al.
BMC Cancer|April 9, 2025
Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohortRiccardo Tajè, Filippo Tommaso Gallina, Mauro Caterino, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Robotic Surgery|March 26, 2023
Multimodal evaluation of locoregional anaesthesia efficacy on postoperative pain after robotic pulmonary lobectomy for NSCLC: a pilot studyRiccardo Tajè, Filippo Tommaso Gallina, Daniele Forcella, et al.
Frontiers in Oncology|December 16, 2022
Perioperative outcomes of robotic lobectomy for early-stage non-small cell lung cancer in elderly patientsFilippo Tommaso Gallina, Riccardo Tajè, Daniele Forcella, et al.
Frontiers in Oncology|November 29, 2023
Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLCFilippo Tommaso Gallina, Daniele Marinelli, Riccardo Tajè, et al.
Journal of Clinical Medicine|April 23, 2022
Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung CancerFilippo Tommaso Gallina, Riccardo Tajè, Daniele Forcella, et al.
Lung Cancer (Amsterdam, Netherlands)|July 30, 2024
Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLCFilippo Tommaso Gallina, Vittoria Balzano, Nicla Porciello, et al.
Clinical Lung Cancer|April 16, 2024
Neutrophil-to-Lymphocyte Ratio and Risk of Nodal Metastasis in Early-Stage Lung Adenocarcinoma: A Brief Report From a Multicentric AnalysisFilippo Tommaso Gallina, Marco Chiappetta, Riccardo Tajè, et al.
Journal of Clinical Pathology|August 17, 2021
Not enough can be enough: feasibility of the Idylla <i>EGFR</i> mutation test when reuse of stained tissue slides is the only option availableCristiana Ercolani, Anna Di Benedetto, Claudia Bonomo, et al.
Cancers|April 23, 2022
Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative ReviewFilippo Tommaso Gallina, Luca Bertolaccini, Daniele Forcella, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2023
ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinomaFilippo Tommaso Gallina, Riccardo Tajè, Fabiana Letizia Cecere, et al.
BMC Cancer|April 9, 2025
Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohortRiccardo Tajè, Filippo Tommaso Gallina, Mauro Caterino, et al.
Pageof 5